Prosecution Insights
Last updated: August 16, 2026
Application No. 18/846,979

METHOD FOR PROVIDING FETUS MONITORING SERVICE AND SERVER FOR PERFORMING SAME

Non-Final OA §112
Filed
Sep 13, 2024
Priority
Mar 16, 2022 — RE 10-2022-0033004 +1 more
Examiner
JANG, CHRISTIAN Y
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Sungkwang Medical Foundation
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
1y 10m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
586 granted / 855 resolved
-1.5% vs TC avg
Strong +21% interview lift
Without
With
+21.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
34 currently pending
Career history
875
Total Applications
across all art units

Statute-Specific Performance

§101
16.9%
-23.1% vs TC avg
§103
38.4%
-1.6% vs TC avg
§102
14.0%
-26.0% vs TC avg
§112
23.4%
-16.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 855 resolved cases

Office Action

§112
DETAILED ACTION Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-8 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 1 and 8 recite the generation of valid data by matching noise-removed data with “pre-stored user information”. It is unclear how this is achieved, whether it generates valid data that’s different from the noise-removed data or if it simply “validates” the noise-removed data. The original disclosure states that this pre-stored user information is user information that is input by the user through the user terminal or from a medical system server and can include personal information such as age, height, and contact information and/or status information, such as weight, body temperature, history of internal and reproductive diseases related to pregnancy, past surgery, and medication user ([0041] of the printed publication). It’s not clear how this information, individually or as a group, can be used to generate valid data. For example, what kind of “valid data” is generated by factoring in the contact information of the user? Where there is a great deal of confusion and uncertainty as to the proper interpretation of the limitations of a claim, it would not be proper to reject such a claim on the basis of prior art. As stated in In re Steele, 305 F.2d 859, 134 USPQ 292 (CCPA 1962), a rejection should not be based on considerable speculation about the meaning of terms employed in a claim or assumptions that must be made as to the scope of the claims. See MPEP 2173.06. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Vaidayanathan et al. (US2016/0262687) teaches fetal monitoring by receiving motion signals and acoustic signals and determining acoustic signals corresponding to fetal movement ([0015]) and uses motion signals to determine period of maternal activity to remove noise from the data by attenuating or excluding maternal acoustic vibration signals to detect acoustic vibrations associated with fetal movement ([0028]). Christensen et al. (USP #8,911,383) teaches an adhesive patch for monitoring bodily acoustic signals in which a first microphone detects acoustic signals from the body and a second microphone is used to record environmental noise signals and removing the environmental noise recorded from the first microphone (col. 5 lines 37-54). Roham et al. (US 2012/0232398) teaches a wireless fetal monitoring system including acoustic sensors ([0026]) and determining fetal and maternal health information ([0030]). Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTIAN JANG whose telephone number is (571)270-3820. The examiner can normally be reached Monday-Friday (7-3:30 EST). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Chen can be reached at 571-272-3672. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. CHRISTIAN JANG Primary Examiner Art Unit 3791 /CHRISTIAN JANG/ Primary Examiner, Art Unit 3791 7/9/26
Read full office action

Prosecution Timeline

Sep 13, 2024
Application Filed
Jul 14, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702332
SYSTEMS, DEVICES, AND METHODS FOR ANALYTE MONITORING
3y 7m to grant Granted Aug 11, 2026
Patent 12697039
WEARABLE BIOIMPEDANCE MONITORING SYSTEM USING CONFORMAL NANOWIRE ELECTRODES
3y 9m to grant Granted Aug 04, 2026
Patent 12690787
Methods and Systems for Continuously Monitoring the Glucose Level of a Patient
3y 10m to grant Granted Jul 28, 2026
Patent 12690789
ACCURACY OF CONTINUOUS GLUCOSE SENSORS
2y 4m to grant Granted Jul 28, 2026
Patent 12678078
INTERFERENT DETECTION IN AN ANALYTE MONITORING SYSTEM
5y 8m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
90%
With Interview (+21.0%)
3y 9m (~1y 10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 855 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month